| Title: |
Impact of daratumumab refractoriness on clinical outcomes following CAR T-cell therapy for relapsed refractory multiple myeloma |
| Authors: |
Sebastian, T.; Rajeeve, S.; Farzana, T.; Firestone, R.; Jurgens, E.; Miller, K.; Costa, B.; Lesokhin, A.; Tan, C.; Shah, G.; Korde, N.; Landau, H.; Scordo, M.; Hassoun, H.; Maclachlan, K.; Shah, U.; Hultcrantz, M.; Derkach, A.; Nemirovsky, D.; Giralt, S.; Usmani, S. Z.; Mailankody, S.; Hashmi, H. |
| Source: |
Blood Cancer Journal ; volume 15, issue 1 ; ISSN 2044-5385 |
| Publisher Information: |
Springer Science and Business Media LLC |
| Publication Year: |
2025 |
| Document Type: |
article in journal/newspaper |
| Language: |
English |
| DOI: |
10.1038/s41408-025-01343-4 |
| Availability: |
https://doi.org/10.1038/s41408-025-01343-4; https://www.nature.com/articles/s41408-025-01343-4.pdf; https://www.nature.com/articles/s41408-025-01343-4 |
| Rights: |
https://creativecommons.org/licenses/by-nc-nd/4.0 ; https://creativecommons.org/licenses/by-nc-nd/4.0 |
| Accession Number: |
edsbas.2491C1BA |
| Database: |
BASE |